Email this article Prognostic value of SYNTAX score for outcomes and revascularization strategy choice in ST-segment elevation myocardial infarction patients with multivessel coronary artery disease
- Authors: Tarasov RS1, Ganiukov VI1, Shilov AA1, Barbarash OL1, Barbarash LS2
-
Affiliations:
- ФГБУ "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний СО РАМН", Кемерово
- Муниципальное учреждение здравоохранения "Кемеровский кардиологический диспансер"
- Issue: Vol 84, No 9 (2012)
- Pages: 17-21
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31075
- ID: 31075
Cite item
Full Text
Abstract
Aim. To study the prognostic significance of the SYNTAX score in the evaluation of outcomes of primary percutaneous coronary interventions (PCIs) and revascularization strategy choice in patients with ST-elevation myocardial infarction (STEMI) with multivessel coronary artery disease. Material and methods. The long-term outcomes of primary PCIs were analyzed in 163 patients with STEMI in terms of the objective assessment of the severity of the coronary bed lesion according to SYNTAX scores. Results. In a cohort of STEMI patients who had undergone primary PCI, the SYNTAX score of ≥23 (a severe lesion) was associated with the higher incidence of acute heart failure (Killip class II) and three-vessel coronary artery disease (odds ratio (OR) 2.8), with the higher risk of death (OR 7.5) and the higher rate of the combined endpoint of death, myocardial infarction, and target vessel revascularization (OR 2.8) as compared with patients with a SYNTAX score of ≤ 22 (a moderate lesion). Conclusion. The SYNTAX score has a prognostic value in assessing the outcomes of primary PCIs in the cohort of STEMI patients with multivessel disease, which can find use in the differential choice of the optimal revascularization strategy and improve treatment results. In the group of patients with a SYNTAX score of ≥ 23, the incomplete revascularization strategy shows the least favorable results as compared to multivessel stenting and staged revascularization.
Full Text
##article.viewOnOriginalSite##About the authors
R S Tarasov
ФГБУ "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний СО РАМН", Кемерово
Email: roman.tarasov@mail.ru
V I Ganiukov
ФГБУ "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний СО РАМН", Кемерово
Email: ganyukov@mail.ru
A A Shilov
ФГБУ "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний СО РАМН", Кемерово
Email: shilik@yandex.ru
O L Barbarash
ФГБУ "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний СО РАМН", Кемерово
Email: olb61@mail.ru
L S Barbarash
Муниципальное учреждение здравоохранения "Кемеровский кардиологический диспансер"
Email: olb61@mail.ru
References
- Corpus R.A., House J.A., Marso S.P. et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004; 148 (3): 493-500.
- Cardarelli F., Bellasi A., Fang-Shu Ou et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am J Cardiol 2009; 103: 766-771.
- Jang Hoon Lee, Hun Sik Park, Shung Chull Chae et al. Wee Hyun Park and Korea Acute Myocardial Infarction Registry Investigators. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2009; 104: 182-89.
- Rasoul S., Ottervanger J.P., de Boer M.J. et al. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis 2009; 20: 415-421.
- Toma M., Buller C.E., Westerhout C.M. et al. for the APEX-AMI Investigators. Nonculprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J 2010; 31: 1701-1707.
- Sorjja P., Gersh B.J., Cox D.A. et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716.
- Jaski B.E., Cohen J.D., Trausch J. et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992; 124: 1427-1433.
- Тарасов Р.С., Ганюков В.И., Барбараш О.Л. и др. Выбор стратегии реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении. Патология кровообращения и кардиохирургия 2011; 2: 33-37.
- Goldstein J.A., Demetriou D., Grines C.L. et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
- Kushner F.G., Hand M., Smith S.C. et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2009; 54: 2205-2241.
- Hanratty C.G., Koyama Y., Rasmussen H.H. et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 2002; 40: 911-916.
- Gibson C.M., Ryan K.A., Murphy S.A. et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999; 34: 974-982.
- Dambrink J.-H.E., Debrauwere J.P., van't Hof A.W.J. et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? Eurointervention 2010; 5: 968-975.
- Papamichael N.D., Michalis L.K. Staged Percutaneous Coronary Intervention for Multivessel STEMI Patients? Hospital Chronicles 2010; Suppl: 58-59.
- Girasis C., Garg S., Räber L. et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 2011; 32 (24): 3115-3127.
